Latest news with #Ejiao
India.com
5 days ago
- Business
- India.com
Bankrupt Pakistan in Massive trouble, Prices of THIS animal touches sky, major crisis looms due to..., China plans to...
Pakistan afraid of India's water strike, makes shocking move against India with China's help, it is... Islamabad: Bankrupt Pakistan is facing a massive economic crisis characterized by high inflation, dwindling foreign reserves, a rising debt burden, and political instability. The situation has raised fears of a possible default and is severely affecting the daily lives of ordinary citizens. Salim Khan, a resident of Pakistan, is facing a severe financial crisis because his source of livelihood — his donkey — died in an accident last week. Salim doesn't have enough money to buy another donkey. Around eight years ago, he had bought a donkey for Rs 30,000, but now the price of a donkey has reached Rs 200,000. It is important to note that in Pakistan, donkey carts are a major means of earning a livelihood for a large section of the poor. However, the rising prices of donkeys have become a major challenge for them. The surge in donkey prices has created an employment crisis for thousands of people like Salim. One of the reasons behind the rising prices of donkeys in Pakistan is its friendly country, China. In China, donkey hides are used to produce a traditional medicine known as Ejiao. Ejiao is believed to enhance strength, boost immunity, and treat conditions like tumors and anemia. As a result, the Chinese are buying large numbers of Pakistani donkeys. This has led to a decline in the donkey population and a sharp rise in their prices. China Imports Donkeys from Around the World It is important to note that China has been importing donkey hides from Africa for years now. However, last year, the African Union, which consists of 55 countries, imposed a ban on the trade of donkey hides in 18 countries. For many years, donkey hides were being sent to China for the production of a traditional medicine called Ejiao. After the ban in Africa, China has had to rely on Pakistan for donkeys. As a result, donkey prices in Pakistan have started to rise. China is also in talks with the Pakistani government to set up donkey farms there. In April this year, a Chinese delegation met with Pakistan's Minister Rana Tanveer Hussain to discuss the issue. China is interested in establishing donkey farms in Pakistan because the local climate is suitable for donkeys.
Yahoo
08-04-2025
- Business
- Yahoo
Asian Dividend Stocks To Watch In April 2025
As global markets grapple with heightened trade tensions and economic uncertainty, the Asian stock market has not been immune to these challenges, experiencing volatility amid new tariff announcements and shifting investor sentiment. In such an environment, dividend stocks can offer a measure of stability and income potential, making them an attractive option for investors seeking resilience in their portfolios. Name Dividend Yield Dividend Rating Yangzijiang Shipbuilding (Holdings) (SGX:BS6) 6.21% ★★★★★★ CAC Holdings (TSE:4725) 5.44% ★★★★★★ Tsubakimoto Chain (TSE:6371) 5.06% ★★★★★★ Intelligent Wave (TSE:4847) 4.57% ★★★★★★ Nissan Chemical (TSE:4021) 4.21% ★★★★★★ ENEOS Holdings (TSE:5020) 4.24% ★★★★★★ HUAYU Automotive Systems (SHSE:600741) 4.48% ★★★★★★ Yamato Kogyo (TSE:5444) 4.35% ★★★★★★ E J Holdings (TSE:2153) 5.47% ★★★★★★ Torigoe (TSE:2009) 5.67% ★★★★★★ Click here to see the full list of 1310 stocks from our Top Asian Dividend Stocks screener. Here's a peek at a few of the choices from the screener. Simply Wall St Dividend Rating: ★★★★☆☆ Overview: Dong-E-E-Jiao Ltd. engages in the research, development, production, and sale of Ejiao along with Chinese patent medicines and health foods, with a market cap of CN¥39.16 billion. Operations: Dong-E-E-Jiao Ltd. generates revenue primarily from the operation of Ejiao and its related products, amounting to CN¥5.92 billion. Dividend Yield: 4.2% Dong-E-E-Jiao Ltd. has shown notable earnings growth, with net income rising to CNY 1.56 billion in 2024 from CNY 1.15 billion the previous year, but its dividend sustainability remains a concern due to a high payout ratio of nearly 100%. Despite being among the top dividend payers in China with a yield of 4.17%, the company's dividends have been volatile and not well covered by earnings or cash flows, impacting reliability for income-focused investors. Dive into the specifics of Dong-E-E-JiaoLtd here with our thorough dividend report. Our expertly prepared valuation report Dong-E-E-JiaoLtd implies its share price may be lower than expected. Simply Wall St Dividend Rating: ★★★★★☆ Overview: China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. operates in the pharmaceutical industry, focusing on the production and distribution of medical products, with a market cap of approximately CN¥55.12 billion. Operations: China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. generates revenue from its primary segments, with CN¥24.24 billion from Pharmaceuticals, CN¥0.88 billion from Printing and Packaging, and CN¥4.17 billion from the Medicines, Equipment Wholesale and Retail Industry Segment. Dividend Yield: 3.1% China Resources Sanjiu Medical & Pharmaceutical's dividend yield of 3.08% ranks it in the top 25% of Chinese dividend payers, supported by a cash payout ratio of 46.9%, indicating solid coverage by cash flows. However, its dividends have been volatile over the past decade, affecting reliability despite recent earnings growth to CNY 3.37 billion in 2024 from CNY 2.85 billion a year earlier and a reasonable earnings payout ratio of 50.2%. Get an in-depth perspective on China Resources Sanjiu Medical & Pharmaceutical's performance by reading our dividend report here. In light of our recent valuation report, it seems possible that China Resources Sanjiu Medical & Pharmaceutical is trading behind its estimated value. Simply Wall St Dividend Rating: ★★★★★★ Overview: Ono Pharmaceutical Co., Ltd. and its subsidiaries engage in the production, purchase, and sale of pharmaceuticals and diagnostic reagents globally, with a market cap of ¥762.34 billion. Operations: Ono Pharmaceutical Co., Ltd. generates revenue of ¥487.33 billion from its pharmaceutical business segment. Dividend Yield: 4.9% Ono Pharmaceutical offers a compelling dividend profile with a yield of 4.93%, placing it in the top quartile of Japanese dividend payers. Its dividends are well-supported by earnings and cash flows, with payout ratios of 50.8% and 49.6%, respectively, ensuring sustainability. Despite recent profit margin declines to 15.2% from last year's 25.6%, dividends have remained stable and reliable over the past decade, although earnings are projected to decrease by an average of 2.5% annually for the next three years. Delve into the full analysis dividend report here for a deeper understanding of Ono Pharmaceutical. Our valuation report unveils the possibility Ono Pharmaceutical's shares may be trading at a discount. Access the full spectrum of 1310 Top Asian Dividend Stocks by clicking on this link. Invested in any of these stocks? Simplify your portfolio management with Simply Wall St and stay ahead with our alerts for any critical updates on your stocks. Simply Wall St is your key to unlocking global market trends, a free user-friendly app for forward-thinking investors. Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. Find companies with promising cash flow potential yet trading below their fair value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include SZSE:000423 SZSE:000999 and TSE:4528. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
Yahoo
05-03-2025
- Business
- Yahoo
Top Asian Dividend Stocks For March 2025
Amid global economic uncertainties and regulatory challenges, Asian markets have been navigating a complex landscape influenced by geopolitical tensions and inflationary pressures. As investors seek stability and income generation in this environment, dividend stocks have emerged as an attractive option due to their potential for providing regular income streams. Identifying strong dividend stocks involves looking for companies with solid financial health, consistent earnings, and a commitment to shareholder returns. Name Dividend Yield Dividend Rating Chongqing Rural Commercial Bank (SEHK:3618) 8.52% ★★★★★★ Wuliangye YibinLtd (SZSE:000858) 3.97% ★★★★★★ CAC Holdings (TSE:4725) 5.19% ★★★★★★ Tsubakimoto Chain (TSE:6371) 4.14% ★★★★★★ Daito Trust ConstructionLtd (TSE:1878) 3.94% ★★★★★★ Nissan Chemical (TSE:4021) 3.87% ★★★★★★ GakkyushaLtd (TSE:9769) 4.31% ★★★★★★ Guangxi LiuYao Group (SHSE:603368) 3.48% ★★★★★★ HUAYU Automotive Systems (SHSE:600741) 4.21% ★★★★★★ Chudenko (TSE:1941) 3.81% ★★★★★★ Click here to see the full list of 1141 stocks from our Top Asian Dividend Stocks screener. Let's review some notable picks from our screened stocks. Simply Wall St Dividend Rating: ★★★★☆☆ Overview: Tsingtao Brewery Company Limited, along with its subsidiaries, is involved in the production, distribution, wholesale, and retail sale of beer products across Mainland China, Hong Kong, Macau, and international markets with a market cap of approximately HK$87.95 billion. Operations: Tsingtao Brewery's revenue primarily stems from its beer production and sales operations in Mainland China, Hong Kong, Macau, and international markets. Dividend Yield: 4% Tsingtao Brewery's dividend profile shows both strengths and weaknesses. The company has a history of stable and growing dividends over the past decade, supported by high-quality earnings with a reasonable payout ratio of 62.6%. However, its current dividend yield of 4.02% is below top-tier levels in Hong Kong, and cash flow coverage is weak with a cash payout ratio at 150.9%. Recent leadership changes are not expected to disrupt its strategic direction or corporate governance stability. Delve into the full analysis dividend report here for a deeper understanding of Tsingtao Brewery. In light of our recent valuation report, it seems possible that Tsingtao Brewery is trading behind its estimated value. Simply Wall St Dividend Rating: ★★★★☆☆ Overview: Dong-E-E-Jiao Co., Ltd. engages in the research, development, production, and sale of Ejiao along with various Chinese patent medicines, health foods, and foods, with a market cap of CN¥37.19 billion. Operations: Dong-E-E-Jiao Co., Ltd.'s revenue primarily comes from the operation of Ejiao and its series of products, totaling CN¥5.62 billion. Dividend Yield: 4% Dong-E-E-Jiao Ltd. offers a mixed dividend profile with a notable yield of 3.96%, placing it among the top 25% in China, though its high payout ratio of 123.8% raises sustainability concerns. Cash flow coverage is reasonable at 72.7%, but past dividend volatility and unreliability are drawbacks for income-focused investors. Recent corporate guidance indicates strong earnings growth, driven by strategic initiatives across pharmaceuticals and health consumer products, which may support future dividend stability if sustained effectively. Get an in-depth perspective on Dong-E-E-JiaoLtd's performance by reading our dividend report here. Our valuation report here indicates Dong-E-E-JiaoLtd may be undervalued. Simply Wall St Dividend Rating: ★★★★★☆ Overview: Ryoden Corporation operates in the sale of factory automation systems, cooling and heating systems, information and communication technologies, facilities systems, and electronics both in Japan and internationally, with a market cap of ¥54.47 billion. Operations: Ryoden Corporation's revenue is derived from the sale of factory automation systems, cooling and heating systems, information and communication technologies, facilities systems, and electronics. Dividend Yield: 4.3% Ryoden's dividend profile is characterized by a strong yield of 4.27%, ranking in the top 25% of Japanese dividend payers. The dividends are well-supported by earnings and cash flows, with payout ratios of 58.1% and 16.9%, respectively, indicating sustainability despite historical volatility over the past decade. Recent share buybacks totaling ¥1,019.47 million signal a commitment to enhancing shareholder returns through flexible capital policies, although past dividend instability may concern some investors seeking reliability. Click to explore a detailed breakdown of our findings in Ryoden's dividend report. Our comprehensive valuation report raises the possibility that Ryoden is priced lower than what may be justified by its financials. Access the full spectrum of 1141 Top Asian Dividend Stocks by clicking on this link. Are any of these part of your asset mix? Tap into the analytical power of Simply Wall St's portfolio to get a 360-degree view on how they're shaping up. Simply Wall St is your key to unlocking global market trends, a free user-friendly app for forward-thinking investors. Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. Find companies with promising cash flow potential yet trading below their fair value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include SEHK:168 SZSE:000423 and TSE:8084. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Sign in to access your portfolio
